Latanoprost versus bimatoprost: Author reply

By Gandolfi S.A.   Cimino L.  

Ophthalmology, Vol. 110, Iss. 9, 2003-09 ,pp. : 1862-1862

Elsevier

Access to resources Recommend Favorite

Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study

By Noecker R.S.   Dirks M.S.   Choplin N.  

American Journal of Ophthalmology, Vol. 137, Iss. 1, 2004-01 ,pp. : 210-211

Elsevier

Access to resources Recommend Favorite

A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension

By Coleman A.L.   Lerner F.   Bernstein P.   Whitcup S.M.   Lumigan/Cosopt Study Group  

Ophthalmology, Vol. 110, Iss. 12, 2003-12 ,pp. : 2362-2368

Elsevier

Access to resources Recommend Favorite

The effect of latanoprost on ocular blood flow

By Harris Alon   Garzozi Hanna   McCranor Lynne   Rechtman Ehud   Yung Chi-Wah   Siesky Brent  

International Ophthalmology, Vol. 29, Iss. 1, 2009-02 ,pp. : 19-26

Springer Publishing Company

Access to resources Recommend Favorite

Latanoprost Exerts Neuroprotective Activity in vitro and in vivo

By Drago F.   Valzelli S.   Emmi I.   Marino A.   Scalia C.C.   Marino V.  

Experimental Eye Research, Vol. 72, Iss. 4, 2001-04 ,pp. : 479-486

Elsevier

Access to resources Recommend Favorite